Herpes zoster in older adults.
Cadogan
Mary P
MP
University of California, Los Angeles, School of Nurning, Los Angeles, California, USA. mcadogan@sonnet.ucla.edu
D000212:Acyclovir / Q000031:analogs & derivatives / Q000627:therapeutic use; D000369:Aged, 80 and over; D000998:Antiviral Agents / Q000627:therapeutic use; D002637:Chest Pain / Q000821:virology; D005260:Female; D005851:Geriatric Nursing; D006562:Herpes Zoster / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D053061:Herpes Zoster Vaccine; D014645:Herpesvirus 3, Human / Q000502:physiology; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000821:virology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D014611:Vaccination; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014775:Virus Activation
D000998:Antiviral Agents; D053061:Herpes Zoster Vaccine; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir